Genmab — November 2020
-
Shaping the Treatment Paradigm Based on the
Current Understanding of the Pathobiology of
Multiple Myeloma: An Overview https://www.mdpi.com/2072-6694/12/11/3488 -
The Lancet - Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trial https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(20)30356-2/fulltext
-
ASH previews https://www.evaluate.com/vantage/articles/events/conferences/ash-2020-preview-novartis-touts-its-tasigna-follow https://twitter.com/UrviShahMD/status/1330382399725854720 https://twitter.com/szusmani/status/1325836427867852800 https://twitter.com/mtmdphd/status/1330894928512249856 https://twitter.com/VincentRK/status/1327357216836513792
-
Artikel om epco-ræset mod Roche i børsen - https://borsen.dk/nyheder/virksomheder/genmab-rival-stiler-efter-at-levere-noget-storartet
-
Roche nedtoner kapløbet
-
Roche taler om at det er kræften, der er fjenden og ikke konkurrerende programmer...
-
Ellers henviser Børsen til JW’s udtalelse om, at Epco’s resultater meget tidlige resultater ser stærkere ud end Roche og Regenerons - og at respons udvider sig med tiden
-
Og at der til ASH kommer opdaterede resultater, der kun er 7 dag gamle
-
“Vi føler os mere og mere sikre på, at vi har et molekyle, der er best-in-class”
-
Så er der da varmet op
-
Roche also recently downplayed the fight with Kesimpta "I think the fact is that the anti-CD 20 pathway is an excellent choice for treating MS. And so I wouldn't be surprised to see Ocrevus growing at the same time that another anti-CD 20 therapy could grow. But again, we see good demand for Ocrevus."
-
Yup
-
Der er ingen grund til at skynde sig ind i aktien.
-
I remember somebody asking or encouraging EL for hacking news - could
there be a connection to Ritzau-gate? -
Hopefully it will bring a smile on a miserable day. Lousy weather and a lousy portfolio today. Yet tomorrow is a new day
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind